Multiple talents of the chemokine receptor-CXCR4

被引:4
作者
Desjardins, Sonia F.
Berchiche, Yamina A.
Haddad, Elie
Heveker, Nikolaus [1 ]
机构
[1] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada
[2] Hop St Justine, Ctr rech 6737, Montreal, PQ H3T 1C5, Canada
[3] Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada
来源
M S-MEDECINE SCIENCES | 2007年 / 23卷 / 11期
关键词
D O I
10.1051/medsci/20072311980
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CXCR4 is a clinically relevant chemokine receptor that has first gained attention as one of the cofactors for HIV entry into target cells. Moreover, the receptor is involved in cancer cell migration to distant metastatic sites and immune effector recruitment in inflammatory diseases such as asthma and rheumatoid arthritis. Unfortunately, pharmacologic intervention is complicated by the vital function of CXCR4 in the organism. The most prominent of these functions is its role in stem cell homing. The CXCR4 chemokine ligand, produced by bone morrow stromal cells, leads both to migration of hematopoietic stem cells towards this niche and their retention in this compartment. As models of G-protein coupled receptor (GPCR) activation evolve, it becomes clear that multiple factors modulate the functional outcome of ligand binding to a receptor. Modulation of GPCR activity, for example by allosteric ligands, may permit more subtle therapeutic approaches adapted to long term treatment. In addition, GPCR signalling can be altered by hetero-oligomerization of GPCRs. In this perspective, it might be possible to achieve modulation of GPCR signalling by also targeting the oligomerization partner of a given receptor. This approach is described using the example of strategies that aim at the optimization of stem cell homing in the context of cord blood-derived hematopoietic stem cell transplantation.
引用
收藏
页码:980 / 984
页数:5
相关论文
共 38 条
[1]   WHIM4 syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12 [J].
Balabanian, K ;
Lagane, B ;
Pablos, JL ;
Laurent, L ;
Planchenault, T ;
Verola, O ;
Lebbe, C ;
Kerob, D ;
Dupuy, A ;
Hermine, O ;
Nicolas, JF ;
Latger-Cannard, W ;
Bensoussan, D ;
Bordigoni, P ;
Baleux, F ;
Le Deist, F ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Bachelerie, F .
BLOOD, 2005, 105 (06) :2449-2457
[2]   The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J].
Balabanian, K ;
Lagane, B ;
Infantino, S ;
Chow, KYC ;
Harriague, J ;
Moepps, B ;
Arenzana-Seisdedos, F ;
Thelen, M ;
Bachelerie, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) :35760-35766
[3]   Umbilical-cord blood transplantation for the treatment of cancer [J].
Barker, JN ;
Wagner, JE .
NATURE REVIEWS CANCER, 2003, 3 (07) :526-532
[4]   Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and Gαi activation [J].
Berchiche, Yamina A. ;
Chow, Ken Y. ;
Lagane, Bernard ;
Leduc, Martin ;
Percherancier, Yann ;
Fujii, Nobutaka ;
Tamamura, Hirokazu ;
Bachelerie, Francoise ;
Heveker, Nikolaus .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (08) :5111-5115
[5]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[6]   Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist [J].
Broxmeyer, HE ;
Orschell, CM ;
Clapp, DW ;
Hangoc, G ;
Cooper, S ;
Plett, PA ;
Liles, WC ;
Li, XX ;
Graham-Evans, B ;
Campbell, TB ;
Calandra, G ;
Bridger, G ;
Dale, DC ;
Srour, EF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1307-1318
[7]  
DELEAN A, 1980, J BIOL CHEM, V255, P7108
[8]   The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways [J].
Ganju, RK ;
Brubaker, SA ;
Meyer, J ;
Dutt, P ;
Yang, YM ;
Qin, SX ;
Newman, W ;
Groopman, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23169-23175
[9]   Uncovering molecular mechanisms involved in activation of G protein-coupled receptors [J].
Gether, U .
ENDOCRINE REVIEWS, 2000, 21 (01) :90-113
[10]   Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome [J].
Gulino, AV ;
Moratto, D ;
Sozzani, S ;
Cavadini, P ;
Otero, K ;
Tassone, L ;
Imberti, L ;
Pirovano, S ;
Notarangelo, LD ;
Soresina, R ;
Mazzolari, E ;
Nelson, DL ;
Notarangelo, LD ;
Badolato, R .
BLOOD, 2004, 104 (02) :444-452